Nanoparticle Drug Delivery for Cartilage Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for osteoarthritis provide only short-term pain relief and do not prevent the degeneration of joint cartilage, leading to complete joint dysfunction and the need for joint replacement, as they fail to penetrate deeply into cartilage and maintain drug concentration in the affected joint.
Innovation Solution
The development of particle-based drug delivery systems using microparticles and nanoparticles functionalized with connective tissue binding compounds, allowing for targeted delivery of therapeutic agents, such as dexamethasone and growth factors, to penetrate and remain in cartilage for sustained release, utilizing particles of specific sizes and charges to facilitate deep tissue penetration and retention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional therapies are administered to treat osteoarthritis, then short-term pain relief is achieved, but the drug fails to penetrate deeply into cartilage and maintain concentration, leading to no protection against cartilage degeneration
Solution Approach 1:
The patent divides the drug delivery system into two distinct particle size components: microparticles (greater than 10 nm) that bind to the cartilage surface and provide sustained release, and nanoparticles (10 nm or less) that penetrate deeply into the cartilage matrix. This segmentation allows each particle type to fulfill its specific function optimally, resolving the contradiction between surface retention and deep penetration
Solution Approach 2:
The patent employs a hierarchical structure where nanoparticles are delivered in conjunction with microparticles. The microparticles serve as surface-bound reservoirs that continuously supply nanoparticles or drug molecules, creating a nested delivery system where larger particles support smaller ones, enabling both sustained surface presence and deep tissue penetration
2Reliability
If microparticles are functionalized with connective tissue binding compounds for targeted delivery, then localized drug delivery to cartilage is improved, but particle size must be optimized to balance surface binding and tissue penetration
Solution Approach 1:
The patent systematically varies critical parameters including particle size (dividing into >10 nm and ≤10 nm categories), surface charge (positive, negative, or neutral), and binding compound types to optimize the balance between cartilage surface affinity and penetration capability. This parameter optimization enables reliable targeted delivery while providing clear design guidelines that reduce complexity
3Duration of action of stationary object
If sustained drug release is achieved through particle-based delivery systems, then cartilage degeneration is inhibited and biosynthesis is promoted, but the system complexity increases compared to conventional therapies
Solution Approach 1:
The particle-based delivery systems are designed to autonomously provide sustained drug release without requiring external intervention. The microparticles naturally bind to cartilage surface proteins, while the controlled degradation of the particle matrix automatically regulates drug release kinetics, enabling long-term therapeutic action through self-sustaining mechanisms that simplify overall system management despite the sophisticated delivery architecture
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables effective, localized delivery of therapeutic agents to deep cartilage zones, providing sustained drug release and reducing systemic side effects, effectively inhibiting cartilage degeneration and promoting biosynthesis, thus addressing the limitations of existing treatments.
Implementation Method 1
utilizing particles of specific sizes and charges to facilitate deep tissue penetration and retention
Implementation Method 2
allowing for targeted delivery of therapeutic agents, such as dexamethasone and growth factors, to penetrate and remain in cartilage
Data Source
AI summary
Microparticles and nanoparticles and compositions thereof are provided. The microparticles and nanoparticles and compositions may be used for the treatment of musculoskeletal disease, such as osteoarthritis and injury such as trauma.